Balaxi Pharmaceuticals Limited (NSE:BALAXI)
India flag India · Delayed Price · Currency is INR
46.20
+0.15 (0.33%)
Sep 17, 2025, 3:29 PM IST

Balaxi Pharmaceuticals Income Statement

Millions INR. Fiscal year is Apr - Mar.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 20212016 - 2020
Period Ending
Jun '25 Mar '25 Mar '24 Mar '23 Mar '22 Mar '21 2016 - 2020
Operating Revenue
2,9772,9262,4133,3642,7942,313
Upgrade
2,9772,9262,4133,3642,7942,313
Upgrade
Revenue Growth (YoY)
23.54%21.25%-28.28%20.42%20.77%406.95%
Upgrade
Cost of Revenue
1,6741,6591,2892,0721,9801,728
Upgrade
Gross Profit
1,3031,2661,1241,293814.24585.36
Upgrade
Selling, General & Admin
990.39894.05656.74727.32312.19160.86
Upgrade
Other Operating Expenses
---0.11-0.26-0.3-1.75
Upgrade
Operating Expenses
1,009912.99677.62744.58317.02162.45
Upgrade
Operating Income
294.13353.21446.44548.12497.22422.9
Upgrade
Interest Expense
-35.7-29.35-16.77-5-1.42-0.13
Upgrade
Interest & Investment Income
-----0.02
Upgrade
Currency Exchange Gain (Loss)
-60.78-60.78-32.7918.6549.4220.5
Upgrade
Other Non Operating Income (Expenses)
24.3323.616.217.46--0
Upgrade
EBT Excluding Unusual Items
221.98286.7403.09569.22545.22443.29
Upgrade
Other Unusual Items
---382.93---
Upgrade
Pretax Income
221.98286.720.15569.22545.22443.29
Upgrade
Income Tax Expense
33.1835.9944.02109.668.6561.92
Upgrade
Net Income
188.8250.7-23.87459.63476.58381.37
Upgrade
Net Income to Common
188.8250.7-23.87459.63476.58381.37
Upgrade
Net Income Growth
-58.45%---3.56%24.96%524.83%
Upgrade
Shares Outstanding (Basic)
555551505050
Upgrade
Shares Outstanding (Diluted)
555551515050
Upgrade
Shares Change (YoY)
5.04%7.26%1.69%1.23%-32.96%
Upgrade
EPS (Basic)
3.424.54-0.469.169.537.63
Upgrade
EPS (Diluted)
3.424.54-0.469.089.537.63
Upgrade
EPS Growth
-60.46%---4.74%24.96%369.94%
Upgrade
Free Cash Flow
--561.2341.74-69.83288.23-12.74
Upgrade
Free Cash Flow Per Share
--10.170.81-1.385.76-0.26
Upgrade
Dividend Per Share
----0.100-
Upgrade
Gross Margin
43.78%43.28%46.58%38.42%29.14%25.30%
Upgrade
Operating Margin
9.88%12.07%18.50%16.29%17.80%18.28%
Upgrade
Profit Margin
6.34%8.57%-0.99%13.66%17.06%16.49%
Upgrade
Free Cash Flow Margin
--19.18%1.73%-2.08%10.32%-0.55%
Upgrade
EBITDA
310.26370.3467.42565.64502.34425.88
Upgrade
EBITDA Margin
10.42%12.66%19.37%16.81%17.98%18.41%
Upgrade
D&A For EBITDA
16.1317.120.9817.535.122.98
Upgrade
EBIT
294.13353.21446.44548.12497.22422.9
Upgrade
EBIT Margin
9.88%12.07%18.50%16.29%17.80%18.28%
Upgrade
Effective Tax Rate
14.95%12.55%218.44%19.25%12.59%13.97%
Upgrade
Revenue as Reported
2,9402,8882,3863,3912,8442,336
Upgrade
Advertising Expenses
-6.416.558.4110.211.02
Upgrade
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.